查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1456976

全球醫療保健外骨骼市場 - 預測 2024-2029

Global Healthcare Exoskeleton Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 103 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

醫療保健外骨骼市場預計將從 2022 年的 332,149,000 美元增加到 2029 年的 1,695,912,000 美元，預測期內複合年成長率為 26.23%。

電化學穿戴設備，通常稱為醫療外骨骼，是作為支持系統而創建的，用於幫助固定患者從損傷中恢復並恢復獨立或完全癱瘓的下肢的運動功能。醫療外骨骼可有效提升步行和恢復運動功能等生物能力。矯正器具等各種小工具也都很有用。這些穿戴式裝置可以為患者提供行動性，甚至保險。醫用外骨骼的存在可以讓患有神經病變、脊髓損傷甚至癱瘓等身體殘疾的人，包括老年人，過上更好的生活。

發展中國家擴大採用外骨骼，這將導致其需求在預測期內不斷增加。此外，外骨骼市場的成長，包括此類設備的進步及其採用，被認為是該市場的一些關鍵驅動力。例如，在 2020 年，所謂的醫療保健公司 GenElex Technologies 有效地研究了這種外部佩戴設備，可以為中風、脊髓損傷甚至癱瘓患者提供支援。同樣，ReWalk 還與德國保險公司 TK 和 DAK-Gesundheit 簽署了幾份契約，為脊髓損傷患者提供機器人外骨骼的有效承保。然而，在這方面，產品發布和相關成本幾乎沒有嚴格的監管核准。

市場促進因素：

  • 身障者和整形外科手術的增加

整形外科手術的興起預計將推動醫療保健外骨骼市場的成長。這是由於更換膝關節或髖關節所需的手術所致。此外，全球患有某種形式身體殘疾的患者數量不斷增加，包括醫療外骨骼保險覆蓋範圍的擴大，預計將成為加速市場成長的因素。例如，根據世界衛生組織 (WHO) 2022 年發布的報告，全球估計有 13 億人，即每 6 人中就有 1 人患有嚴重殘疾。

由於交通事故和各種疾病造成的損傷和傷害，需要各種肢體截肢。據報道，患壞疽的糖尿病患者截肢率也有所增加。此外，數量的增加對市場成長產生了積極作用。根據英國公共衛生局國家心血管情報網發布的糖尿病足部護理概況的資料，下肢截肢率持續上升。

由於上述原因，醫療外骨骼的採用不斷增加。隨著對有效復健方法的需求不斷增加，外骨骼設備的進步被認為是進一步加速市場成長的另一個成長要素。這包括使用新的、先進的技術和產品，這些技術和產品很快​​就會推動醫療保健外骨骼的發展，從而加速醫療保健外骨骼的成長。

  • 對有效復健方法的需求不斷增加

全球對高效復健技術（包括新穎、尖端產品和技術的應用）的需求正在不斷成長。預計這將推動醫療外骨骼市場在所有重要地區的擴張。因此，它會影響整個預測期內的市場動態。

此外，隨著身體缺陷人數的增加，醫療外骨骼市場將顯著發展。由於老年人口增加以及一些國家推出醫療外骨骼保險等原因，醫療外骨骼市場正在加速擴張。此外，嚴重傷害、中風和道路事故發生頻率的增加可能會加快市場開拓的步伐。

預計北美將佔據大部分市場佔有率

據說北美在醫療保健外骨骼市場中佔有重要佔有率。不僅如此，中風和慢性病的盛行率不斷增加，復健中心的增加，住院率的需求，處方箋的增加，政府撥款的增加，包括主要醫療費用的增加，最後是技術的發展意識的提高被認為是推動北美醫療外骨骼市場強勁成長的主要原因。主要醫療外骨骼製造商的強大存在也是醫療外骨骼在北美廣泛採用的原因之一。

同時，亞太地區也因越來越多的外骨骼開發商而受到認可，他們高效、積極地以可承受的成本參與開發創新的醫療外骨骼。由於中風盛行率增加、人口老化加劇、相關健康狀況、有利的政府政策以及醫療保健支出增加是推動市場的一些因素，亞太地區預計將以有利的速度成長。事實確實如此。根據聯合國亞洲及太平洋經濟社會委員會（ESCAP）統計，亞太地區人口老化速度比世界上任何其他地區都要快，預計到2050年這一數字將增加至13億。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現
  • CXO觀點

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章全球醫療保健外骨骼市場：按類型

  • 介紹
  • 動力外骨骼
    • 市場機會和趨勢
    • 成長前景
  • 被動外骨骼
    • 市場機會和趨勢
    • 成長前景

第6章全球醫療保健外骨骼市場：按局部

  • 介紹
  • 下肢
    • 市場機會和趨勢
    • 成長前景
  • 上端
    • 市場機會和趨勢
    • 成長前景

第7章全球醫療保健外骨骼市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 台灣
    • 泰國
    • 印尼
    • 其他

第8章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 有競爭力的儀表板

第9章 公司簡介

  • Rex Bionics Ltd.
  • ReWalk Robotics
  • Ekso Bionics
  • MARSI BIONICS, SL
  • B-Temia Inc.
  • Hocom
  • Myomo Inc
  • Honda Motor Co., Ltd.
簡介目錄
Product Code: KSI061612298

The global healthcare exoskeleton market is projected to grow at a CAGR of 26.23% during the forecast period to reach US$1,695.912 million in 2029 from US$332.149 million in 2022.

An electrochemical wearable device is commonly known as a medical exoskeleton which was created as a support system for patients in helping them with mobility difficulties to recover from their injuries and their motor functions in their party or even fully paralyzed lower extremities. The healthcare exoskeleton is efficient in improving biological abilities such as helping people to walk again or gain their motor function. There are various gadgets such as orthotic devices which are also beneficial. These wearable gadgets allow the patient to gain mobility strength and even insurance. Those individuals living with physical disabilities such as neurological disorders, spinal cord injuries, and even paralysis including elderly individuals live better due to the presence of medical exoskeletons.

The rising adoption of exoskeletons in developing countries will result in adding to their demand over the projected period. Furthermore, the increase in the market of exoskeletons including advancements and their adoption of such devices is regarded to be a few major driving forces for this market. For instance, in 2020, GenElex Technologies, which is regarded to be a healthcare firm efficiently worked on the external wearing of this device which can support people with stroke, spinal cord injury, and even paralysis. Similarly, ReWalk has entered into a few agreements with insurers TK and DAK-Gesundheit in Germany to provide effective coverage of robotic exoskeletons for individuals suffering from spinal cord injuries. However, in this regard, there are few stringent regulatory approvals for product launches and the costs associated with them.

MARKET DRIVER:

  • An increasing number of people with physical disabilities and orthopedic surgeries

The increase in the number of orthopedic surgeries is expected to drive the healthcare exoskeleton market toward growth. This is due to the operation necessary for knee and hip joint replacements. Moreover, the increasing number of patients suffering from some form of physical disability across the globe including the growing insurance coverage for the healthcare exoskeleton is a factor that is expected to accelerate the growth of the market. For example, according to the report published by the World Health Organization in 2022, an estimated 1.3 billion people or 1 in 6 people worldwide experience significant disability.

Various amputations of limbs have been performed which is due to the number of damages and injuries caused by multiple road accidents or even by various diseases. A rise in such amputation operations has been reported in those patients with diabetes who have also developed gangrene. Moreover, this rising number is positively favoring the growth of the market. Data from Diabetes Foot Care Profiles, published by PHEs National Cardiovascular Intelligence Network indicates that lower limb amputations continue to rise.

Due to the above reasons, the market continues to witness an increase in the adoption of healthcare exoskeletons. The advancements of exoskeleton devices which further will accelerate the growth of the market followed by a growing demand for effective rehabilitation approaches are regarded to be another growth factor. This includes the use of new and advanced technologies and products that have prompted the development of the healthcare exoskeleton, thereby driving the growth of healthcare exoskeleton shortly.

  • Increasing demand for efficient methods of rehabilitation

The demand for efficient rehabilitation techniques, including the application of novel and cutting-edge goods and technologies, is growing on a global scale. This is seen as encouraging for the medical exoskeleton market's expansion in all important regions. Influence market dynamics as a result throughout the projected term.

In addition, the market for medical exoskeletons will develop significantly as the number of persons with physical limitations rises. The medical exoskeleton market is expanding at an accelerated rate due to reasons such as the growing senior population and the increased availability of medical exoskeleton insurance coverage in several nations. In addition, a rise in the frequency of serious injuries, strokes, and traffic accidents will accelerate the market's development pace.

North America is anticipated to hold a significant amount of the market share

North America is said to hold a significant amount of market share for the market of healthcare exoskeleton. Not only this but the prevalence of increasing strokes, and chronic illness, followed by the increase in the number of rehabilitation centers, the demand in hospitalization rates, rise in prescriptions, increasing funding by the government including the key healthcare expenditure, and lastly the growing awareness of technological developments are regarded to be major reasons which are imperatively driving North American healthcare exoskeleton market towards growth. The strong presence of key medical exoskeleton players is also another reason for the high uptake of the medical exoskeleton in North America.

On the other hand, APAC is also regarded to account for a growing number of exoskeleton developers who are efficiently and actively involved in the development of innovative medical exoskeletons at affordable costs. APAC is projected to grow at a lucrative rate due to an increase in stroke incidence, a growing aging population, related health conditions, favorable government policies, and increasing healthcare expenditures are some of the factors driving the market. According to the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), the Asia-Pacific population is aging faster than any other region in the world as by 2050, the number is projected to increase to 1.3 billion.

Market Key Developments

  • August 2023- ReWalk Robotics has announced a definitive agreement to acquire AlterG, a leading provider of Anti-Gravity systems for physical and neurological rehabilitation. The acquisition will expand ReWalk's neurorehabilitation product portfolio and add AlterG's current and future product lines. The deal is expected to significantly expand ReWalk's customer-facing capabilities and advance future growth opportunities. AlterG is a leader in transformative technology that empowers people to recover mobility, improve wellness, and enhance physical performance.

Segmentation:

By Type

  • Powered Exoskeleton
  • Passive Exoskeleton

By Extremity

  • Lower Extremity
  • Upper Extremity

By Geography

  • North America
  • USA
  • Canada
  • Others
  • South America
  • Brazil
  • Others
  • Europe
  • Germany
  • UK
  • France
  • Others
  • Middle East and Africa
  • Israel
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key Benefits to the stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL HEALTHCARE EXOSKELETON MARKET, BY TYPE

  • 5.1. Introduction
  • 5.2. Powered Exoskeleton
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
  • 5.3. Passive Exoskeleton
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects

6. GLOBAL HEALTHCARE EXOSKELETON MARKET, BY EXTREMITY

  • 6.1. Introduction
  • 6.2. Lower Extremity
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
  • 6.3. Upper Extremity
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects

7. GLOBAL HEALTHCARE EXOSKELETON MARKET, BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. United States
      • 7.2.1.1. Market Opportunities and Trends
      • 7.2.1.2. Growth Prospects
    • 7.2.2. Canada
      • 7.2.2.1. Market Opportunities and Trends
      • 7.2.2.2. Growth Prospects
    • 7.2.3. Mexico
      • 7.2.3.1. Market Opportunities and Trends
      • 7.2.3.2. Growth Prospects
  • 7.3. South America
    • 7.3.1. Brazil
      • 7.3.1.1. Market Opportunities and Trends
      • 7.3.1.2. Growth Prospects
    • 7.3.2. Argentina
      • 7.3.2.1. Market Opportunities and Trends
      • 7.3.2.2. Growth Prospects
    • 7.3.3. Others
      • 7.3.3.1. Market Opportunities and Trends
      • 7.3.3.2. Growth Prospects
  • 7.4. Europe
    • 7.4.1. United Kingdom
      • 7.4.1.1. Market Opportunities and Trends
      • 7.4.1.2. Growth Prospects
    • 7.4.2. Germany
      • 7.4.2.1. Market Opportunities and Trends
      • 7.4.2.2. Growth Prospects
    • 7.4.3. France
      • 7.4.3.1. Market Opportunities and Trends
      • 7.4.3.2. Growth Prospects
    • 7.4.4. Italy
      • 7.4.4.1. Market Opportunities and Trends
      • 7.4.4.2. Growth Prospects
    • 7.4.5. Spain
      • 7.4.5.1. Market Opportunities and Trends
      • 7.4.5.2. Growth Prospects
    • 7.4.6. Others
      • 7.4.6.1. Market Opportunities and Trends
      • 7.4.6.2. Growth Prospects
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
      • 7.5.1.1. Market Opportunities and Trends
      • 7.5.1.2. Growth Prospects
    • 7.5.2. UAE
      • 7.5.2.1. Market Opportunities and Trends
      • 7.5.2.2. Growth Prospects
    • 7.5.3. Others
      • 7.5.3.1. Market Opportunities and Trends
      • 7.5.3.2. Growth Prospects
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Market Opportunities and Trends
      • 7.6.1.2. Growth Prospects
    • 7.6.2. China
      • 7.6.2.1. Market Opportunities and Trends
      • 7.6.2.2. Growth Prospects
    • 7.6.3. India
      • 7.6.3.1. Market Opportunities and Trends
      • 7.6.3.2. Growth Prospects
    • 7.6.4. South Korea
      • 7.6.4.1. Market Opportunities and Trends
      • 7.6.4.2. Growth Prospects
    • 7.6.5. Taiwan
      • 7.6.5.1. Market Opportunities and Trends
      • 7.6.5.2. Growth Prospects
    • 7.6.6. Thailand
      • 7.6.6.1. Market Opportunities and Trends
      • 7.6.6.2. Growth Prospects
    • 7.6.7. Indonesia
      • 7.6.7.1. Market Opportunities and Trends
      • 7.6.7.2. Growth Prospects
    • 7.6.8. Others
      • 7.6.8.1. Market Opportunities and Trends
      • 7.6.8.2. Growth Prospects

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Rex Bionics Ltd.
  • 9.2. ReWalk Robotics
  • 9.3. Ekso Bionics
  • 9.4. MARSI BIONICS, S.L
  • 9.5. B-Temia Inc.
  • 9.6. Hocom
  • 9.7. Myomo Inc
  • 9.8. Honda Motor Co., Ltd.